Publications by authors named "E Rorer"
Article Synopsis
- In 2019, the FDA warned that devices coated with paclitaxel for treating claudication might be linked to higher mortality rates over five years, prompting a study to explore patient preferences between risks of revascularization and mortality.
- A survey involving 272 patients from seven medical centers used discrete-choice experiments to assess how much increased mortality risk they would accept in exchange for decreased chances of needing further procedures on their blood vessels.
- Results indicated that patients would generally tolerate a small increase in 5-year mortality risk (up to 12.6%) to achieve significant reductions in treatment risks, though there was notable variability in individual risk tolerance, highlighting the need for tailored decision-making support.
Introduction: Despite decades of research on risk-communication approaches, questions remain about the optimal methods for conveying risks for different outcomes across multiple time points, which can be necessary in applications such as discrete choice experiments (DCEs). We sought to compare the effects of 3 design factors: 1) separated versus integrated presentations of the risks for different outcomes, 2) use or omission of icon arrays, and 3) vertical versus horizontal orientation of the time dimension.
Methods: We conducted a randomized study among a demographically diverse sample of 2,242 US adults recruited from an online panel (mean age 59.